The central neuropharmcology of psychotropic cannabinoids

https://doi.org/10.1016/0163-7258(88)90106-4Get rights and content

First page preview

First page preview
Click to open first page preview

References (294)

  • A.S. Bloom

    Effects of cannabinoids on neurotransmitter receptors in the brain

  • A.S. Bloom et al.

    Effects of delta-9-tetrahydrocannabinol on ATPases in mouse brain subcellular fractions

    Life Sci.

    (1978)
  • M.B. Bowers et al.

    Regional brain homovanillic acid following delta-9-tetrahydrocannabinol and cocaine

    Brain Res.

    (1986)
  • E.H. Boyd et al.

    Differential effects of a tetrahydrocannabinol and pentobarbital on cerebral cortical neurones

    Neuropharmacology

    (1975)
  • R.O. Brady et al.

    Comparisons of the effects of delta-9-tetrahydrocannabinol, 11-hydroxy-delta-9-tetrahydrocannabinol and ethanol on the electrophysiological activity of the giant axon of the squid

    Neuropharmacology

    (1973)
  • R.S. Britton et al.

    Lysis of rat liver lysosomes in vitro by delta-9-tetrahydrocannabinol

    Biochem. Pharmac.

    (1974)
  • E.P. Bruggemann et al.

    Alterations in the organization of phosphatidylcholine/cholesterol bilayers by tetrahydrocannabinol

    J. Biol. Chem.

    (1983)
  • S. Burstein et al.

    Prostaglandins and cannabis—VI. Release of arachidonic acid from HeLa cells by delta-1-tetrahydrocannabinol and other cannabinoids

    Biochem. Pharmac.

    (1978)
  • S. Burstein et al.

    The role of prostaglandins in the actions of the cannabinoids

  • S. Burstein et al.

    Inhibition of prostaglandin E2 biosynthesis by delta-1-tetrahydrocannabinol

    Prostaglandins

    (1972)
  • S. Burstein et al.

    Prostaglandins and cannabis—II. Inhibition of biosynthesis by the naturally occurring cannabinoids

    Biochem. Pharmac.

    (1973)
  • S. Burstein et al.

    Inhibition of cholesterol esterases by delta-1-tetrahydrocannabinol

    Life Sci.

    (1978)
  • S. Burstein et al.

    Prostaglandins and cannabis—IX. Stimulation of prostaglandin E2 synthesis in human lung fibroblasts by delta-1-tetrahydrocannabinol

    Biochem. Pharmac.

    (1982)
  • S. Burstein et al.

    Prostaglandins and cannabis—XI. Inhibition of delta-1-tetrahydrocannabinol-induced hypotension by aspirin

    Biochem. Pharmac.

    (1982)
  • S. Burstein et al.

    Prostaglandins and cannabis—XIII. Cannabinoid-induced elevation of lipoxygenase products in mouse peritoneal macrophages

    Biochem. Pharmac.

    (1984)
  • S. Burstein et al.

    Prostaglandins and cannabis—XV. Comparison of enantiomeric cannabinoids in stimulating prostaglandin synthesis in fibroblasts

    Life Sci.

    (1986)
  • S. Burstein et al.

    Prostaglandins and cannabis—XVI. Antagonism of delta-1-tetrahydrocannabinol action by its metabolites

    Biochem. Pharmac.

    (1986)
  • A. Chari-Bitron

    Stabilization of rat erythrocyte membrane by delta-1-tetrahydrocannabinol

    Life Sci.

    (1971)
  • A. Chari-Bitron et al.

    Effect of delta-1-tetrahydrocannabinol on ATPase activity of rat liver mitochondria

    Biochem. Pharmac.

    (1971)
  • P. Consroe et al.

    Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice

    Eur. J. Pharmac.

    (1982)
  • L.H. Conti et al.

    The effects of delta-9-tetrahydrocannabinol injections to the nucleus accumbens on the locomotor activity of rats

  • S. Dalterio et al.

    Direct and pituitary-mediated effects of delta-9-THC and cannabinol on the testis

    Pharmac. Biochem. Behav.

    (1978)
  • T.W. Dolby et al.

    Effects of delta-9-tetrahydrocannabinol on the levels of cyclic adenosine 3′,5′-monophosphate in mouse brain

    Biochem. Pharmac.

    (1974)
  • E.F. Domino et al.

    Effects of various psychotomimetic agents on the EEG and acetylcholine release from the cerebral cortex of brain-stem transected cats

    Neuropharmacology

    (1972)
  • D.M. Feeney

    Marihuana and epilepsy: Paradoxical anticonvulsant and convulsant effects

  • M.R. Foy et al.

    Delta-9-THC and 17-beta-estradiol in hippocampus

    Brain Res. Bull.

    (1982)
  • E.R. Garrett et al.

    Physicochemical properties, solubility and protein binding of delta-9-tetrahydrocannabinol

    J. Pharm. Sci.

    (1974)
  • E.W. Gill et al.

    Brain levels of delta-1-tetrahydrocannabinol and its metabolites in mice—Correlation with behaviour and the effect of the metabolic inhibitors SKF 525A and piperonyl butoxide

    Biochem. Pharmac.

    (1972)
  • E.W. Gill et al.

    Blood and brain levels of delta-1-tetrahydrocannabinol in mice—The effect of 7-hydroxy-delta-1-tetrahydrocannabinol

    Biochem. Pharmac.

    (1974)
  • E.W. Gill et al.

    Contribution of the metabolite 7-OH-delta-1-tetrahydrocannabinol towards the pharmacological activity of delta-1-tetrahydrocannabinol in mice

    Biochem. Pharmac.

    (1973)
  • A.A. Abdel-Latif

    Calcium-mobilizing receptors, polyphosphoinositides, and the generation of second messengers

    Pharmac. Rev.

    (1986)
  • J. Acosta-Urquidi et al.

    The effects of delta-9-tetrahydrocannabinol on action potentials in the mollusc Aplysia

    Can. J. Physiol. Pharmac.

    (1975)
  • A.K. Agrawal et al.

    Cannabis and central dopaminergic transmission: effect on receptor sensitivity and behavioral modulation

    Res. Commun. Subst. Abuse

    (1985)
  • S. Agurell et al.

    Pharmacokinetics and metabolism of delta-1-tetrahydrocannabinol and other cannabinoids with emphasis on man

    Pharmac. Rev.

    (1986)
  • W.E. Askew et al.

    Effects of tetrahydrocannabinols on cyclic AMP levels in rat brain areas

    Experientia

    (1974)
  • D. Ayalon et al.

    Acute effect of delta-1-tetrahydrocannabinol on the hypothalamo-pituitary-ovarian axis in the rat

    Neuroendocrinology

    (1977)
  • S.P. Banerjee et al.

    Cannabinoids: Influence on neurotransmitter uptake in rat brain synaptosomes

    J. Pharmac. Exp. Ther.

    (1975)
  • A. Banerjee et al.

    Action of delta-9-tetrahydrocannabinol on membrane-bound monoamine oxidase activity

    Toxicol. Appl. Pharmac.

    (1977)
  • P.M. Beardsley et al.

    Dependence on tetrahydrocannabinol in rhesus monkeys

    J. Pharmac. Exp. Ther.

    (1986)
  • D. Bensemana et al.

    Effect of delta-9-THC on the distribution uptake and release of catecholamine in rats

    Rev. Can. Biol.

    (1974)
  • Cited by (130)

    • Cannabinoids and mitochondria

      2021, Mitochondrial Physiology and Vegetal Molecules: Therapeutic Potential of Natural Compounds on Mitochondrial Health
    • Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads

      2017, Advances in Pharmacology
      Citation Excerpt :

      Conversely, THC inhibits T-type calcium (Cav3) voltage-gated ion channels, potassium Kv1.2 voltage-gated ion channels, conductance in Na+ voltage-gated ion channels (−), and conductance in gap junctions between cells at concentrations between 1 and 10 μM. THC can also interact with a variety of enzymes such as phosphlipases, lysophosphatidylcholine acyl transferase, lipoxygenase, Na+-K+-ATPase, Mg2 +-ATPase, CYP1A1, CYP1A2, CYP1B1, CYP2B6, CYP2C9, and monoamine oxidase activity (Evans, 1991; Pertwee, 1988; Pertwee & Cascio, 2014; Yamaori et al., 2012; Yamaori, Kushihara, Yamamoto, & Watanabe, 2010; Yamaori, Okamoto, Yamamoto, & Watanabe, 2011). The synaptic conversion of tyrosine to noradrenaline and dopamine (DA) is increased by THC while norepinephrine-induced melatonin biosynthesis is inhibited.

    • Neurosteroids and potential therapeutics: Focus on pregnenolone

      2016, Journal of Steroid Biochemistry and Molecular Biology
      Citation Excerpt :

      Recently, our group discovered that PREG was capable of reducing central cannabinoid effects, which are mediated by the type-1 cannabinoid (CB1) receptor, the most abundant G protein coupled receptor (GPCR). CB1 receptor is expressed widely within the brain [140] and is the main target of the major psychoactive component of Cannabis sativa, delta-9 tetrahydrocannabinol (THC) [114]. We discovered that the inhibitory action of PREG on THC-mediated effects involved CB1 receptors.

    • CB1 Receptor-Mediated Signaling Mechanisms in the Deleterious Effects of Spice Abuse

      2016, Neuropathology of Drug Addictions and Substance Misuse
    View all citing articles on Scopus
    View full text